Guowei Su
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2020First federal award
$6.5MFederal grants as PI7 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
7 awards · $6.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 31, 2025 | NIH | SBIR Phase II Synthesis of the library of heparan sulfate hexasaccharide mimetics | $1.1M | GLYCAN THERAPEUTICS CORPORATION |
| Sep 2, 2024 | NIH | SBIR Phase II Synthesis of the library of heparan sulfate hexasaccharide mimetics | $1.1M | GLYCAN THERAPEUTICS CORPORATION |
| Sep 21, 2023 | NIH | SBIR Phase I Synthesis of the library of heparan sulfate hexasaccharide mimetics | $255K | GLYCAN THERAPEUTICS CORPORATION |
| Jan 24, 2023 | NIH | SBIR Phase I Development of a sensitive method to measure heparan sulfate 6-O-endosulfatase | $350K | GLYCAN THERAPEUTICS CORPORATION |
| May 1, 2022 | NIH | SBIR Phase I Construction of chondroitin sulfate microarray | $332K | GLYCAN THERAPEUTICS CORPORATION |
| May 10, 2021 | NIH | SBIR Phase II Developing Heparan Sulfate Glycan Array | $968K | GLYCAN THERAPEUTICS CORPORATION |
| May 1, 2020 | NIH | SBIR Phase II Developing Heparan Sulfate Glycan Array | $2.4M | GLYCAN THERAPEUTICS CORPORATION |
Peer ranks
Federal funding#162
Awards as PI#250
Patents#273
Companies
- GLYCAN THERAPEUTICS CORPORATIONLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.